(Q50760156)
Statements
The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides (English)
M S Shearman
S R Hawtin
scientific article published in July 1995